Hornet Therapeutics emerges from stealth with data published in Science demonstrating the first potential drug intervention for Epstein-Barr Virus (EBV) driven disease

Press Release Hornet Therapeutics emerges from stealth with data published in Science demonstrating the first potential drug intervention for Epstein-Barr Virus (EBV) driven disease 4BIO Capital

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,London ,City Of ,Jonathan Edwards ,Dmitry Kuzmin ,Christoph Hess ,Amber Fennell ,Fraser Gray ,Human Services ,University Of Cambridge ,Transplantation Network ,Worldwide Business Development At Glaxosmithkline ,Ius Dept Of Health ,University Of Basel ,Epstein Barr Virus ,Kyowa Kirin ,Multiple Sclerosis ,Infectious Mononucleosis ,Hornet Therapeutics ,Vice President ,Infectious Diseases ,Worldwide Business Development ,Professor Christoph Hess ,Experimental Medicine ,Chief Scientific Officer ,Chief Executive Officer ,Managing Partner ,Ihr Portfolio ,